Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
29.04.2025 15:31:17
|
Abbott Partners Epic To Integrate Libre CGM Data Into U.S. Health Record Systems
(RTTNews) - Abbott Laboratories (ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology, announced Tuesday that it has entered a first-of-its-kind agreement with healthcare software company Epic Systems Corp. to integrate data from Abbott's world-leading Libre CGM systems directly into Epic's electronic health record systems in the U.S.
The collaboration aims to improve workflow efficiency for providers through Epic's Aura software, which brings health systems together with diagnostics labs and medical device manufacturers.
Through this integration, data from a user's LibreView account can be automatically linked to Epic, allowing clinicians to effortlessly view their patients' glucose data within Epic before, during and after meeting with their patients.
This seamless process ensures healthcare providers can access key glucose data directly within their preferred workflows, enabling more informed care.
With Libre systems and Epic, patients can more easily collaborate with their providers and utilize advanced CGM technology that can lead to improved patient engagement and behavior change.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratories
|
16.07.26 |
Zurückhaltung in New York: S&P 500 legt schlussendlich den Rückwärtsgang ein (finanzen.at) | |
|
16.07.26 |
Schwacher Handel: NASDAQ Composite schließt mit Verlusten (finanzen.at) | |
|
16.07.26 |
NYSE-Handel S&P 500 fällt am Donnerstagnachmittag (finanzen.at) | |
|
16.07.26 |
Börse New York in Rot: NASDAQ Composite sackt nachmittags ab (finanzen.at) | |
|
16.07.26 |
Zurückhaltung in New York: NASDAQ Composite verbucht mittags Verluste (finanzen.at) | |
|
16.07.26 |
Angespannte Stimmung in New York: S&P 500 fällt am Mittag (finanzen.at) | |
|
16.07.26 |
NASDAQ Composite Index-Papier Abbott Laboratories-Aktie: So viel hätten Anleger mit einem Investment in Abbott Laboratories von vor 10 Jahren verdient (finanzen.at) | |
|
16.07.26 |
Börse New York in Rot: NASDAQ Composite präsentiert sich zum Start des Donnerstagshandels leichter (finanzen.at) |
Analysen zu Abbott Laboratories
Aktien in diesem Artikel
| Abbott Laboratories | 87,86 | 2,16% |
|